ATXS

Astria Therapeutics, Inc.

12.94 USD
+0.32 (+2.54%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Astria Therapeutics, Inc. stock is up 52.24% since 30 days ago. The next earnings date is Mar 20, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 22.22% of the previous 8 February’s closed higher than January. In the last 5 Unusual Options Trades, there were 4 CALLs, 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
25 Jan 19:56 19 Apr, 2024 7.50 CALL 211 425
29 Jan 19:55 19 Apr, 2024 15.00 CALL 332 10104
29 Jan 19:55 19 Jul, 2024 12.50 CALL 111 43
30 Jan 20:32 19 Apr, 2024 17.50 CALL 2000 0
22 Feb 19:24 19 Apr, 2024 10.00 PUT 233 109

About Astria Therapeutics, Inc.

Astria Therapeutics, Inc. was incorporated in 2008 and is based in Boston, Massachusetts. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary angioedema.